{
    "organizations": [],
    "uuid": "871ea5e271e9b56fe763a7a455918ec351857dc1",
    "author": "",
    "url": "https://www.reuters.com/article/brief-glaxosmithkline-says-updated-marke/brief-glaxosmithkline-says-updated-marketing-authorisation-by-european-commission-will-be-reflected-in-label-for-relvar-ellipta-idUSFWN1QQ08X",
    "ord_in_thread": 0,
    "title": "BRIEF-Glaxosmithkline Says Updated Marketing Authorisation By European Commission Will Be Reflected In Label For Relvar Ellipta",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8, 2018 / 8:11 AM / Updated 24 minutes ago BRIEF-Glaxosmithkline Says Updated Marketing Authorisation By European Commission Will Be Reflected In Label For Relvar Ellipta Reuters Staff 1 Min Read March 8 (Reuters) - Glaxosmithkline Plc: * UPDATED MARKETING AUTHORISATION BY EUROPEAN COMMISSION WILL BE REFLECTED IN LABEL FOR RELVAR ELLIPTA FOR COUNTRIES IN EUROPEAN UNIONâ€‹ Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)",
    "published": "2018-03-08T10:10:00.000+02:00",
    "crawled": "2018-03-08T10:40:42.068+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "updated",
        "minute",
        "ago",
        "say",
        "updated",
        "marketing",
        "authorisation",
        "european",
        "commission",
        "reflected",
        "label",
        "relvar",
        "ellipta",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "glaxosmithkline",
        "plc",
        "updated",
        "marketing",
        "authorisation",
        "european",
        "commission",
        "reflected",
        "label",
        "relvar",
        "ellipta",
        "country",
        "european",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}